Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in T2DM
NCT04014192Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin, empagliflozin, canagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
dapagliflozinempagliflozincanagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04014192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04014192.